You are here

  • Home
  • Archive
  • Volume 25, Issue 6
  • Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

Citation Tools

Article menu
Download PDFPDF
Ovarian Cancer
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sayal K, Gounaris I, Basu B, et al
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study
International Journal of Gynecologic Cancer 2015;25:977-984.